Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
46.94 (1y: +13%)
Market Cap 16.19 B P/E(ttm) 14.10
Enterprise Value 18.12 B P/B 2.60
CAH- NYSE (USA)
Cardinal Health Inc
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$46.94
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 0.786
CAH's Cash to Debt is ranked lower than
2941174% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.09 vs. CAH: 0.786 )
CAH' s 10-Year Cash to Debt Range
Min: 0.3   Max: 1.29
Current: 0.79
0.3
1.29
Equity to Asset 0.076
CAH's Equity to Asset is ranked lower than
3225803% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.37 vs. CAH: 0.076 )
CAH' s 10-Year Equity to Asset Range
Min: 0.07   Max: 0.3
Current: 0.08
0.07
0.3
Interest Coverage 18.9
CAH's Interest Coverage is ranked lower than
3333330% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 92.60 vs. CAH: 18.9 )
CAH' s 10-Year Interest Coverage Range
Min: 9   Max: 24
Current: 18.9
9
24
F-Score: 6
Z-Score: 4.93
M-Score: -2.37
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating margin (%) 1.70
CAH's Operating margin (%) is ranked lower than
3030300% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.00 vs. CAH: 1.70 )
CAH' s 10-Year Operating margin (%) Range
Min: 1.3   Max: 4.2
Current: 1.7
1.3
4.2
Net-margin (%) 1
CAH's Net-margin (%) is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.90 vs. CAH: 1 )
CAH' s 10-Year Net-margin (%) Range
Min: 0.7   Max: 2.5
Current: 1
0.7
2.5
ROE (%) 17.1
CAH's ROE (%) is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.20 vs. CAH: 17.1 )
CAH' s 10-Year ROE (%) Range
Min: 11.8   Max: 26.2
Current: 17.1
11.8
26.2
ROA (%) 4.4
CAH's ROA (%) is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.30 vs. CAH: 4.4 )
CAH' s 10-Year ROA (%) Range
Min: 3.2   Max: 8.3
Current: 4.4
3.2
8.3
ROC (Joel Greenblatt) (%) 58.00
CAH's ROC (Joel Greenblatt) (%) is ranked lower than
3225803% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.10 vs. CAH: 58.00 )
CAH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 29.4   Max: 58
Current: 58
29.4
58
Revenue Growth (%) 2.9
CAH's Revenue Growth (%) is ranked lower than
6249994% of the 16 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.90 vs. CAH: 2.9 )
CAH' s 10-Year Revenue Growth (%) Range
Min: 2.9   Max: 15.6
Current: 2.9
2.9
15.6
EBITDA Growth (%) -1
CAH's EBITDA Growth (%) is ranked lower than
5882347% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.90 vs. CAH: -1 )
CAH' s 10-Year EBITDA Growth (%) Range
Min: -8.5   Max: 11.9
Current: -1
-8.5
11.9
EPS Growth (%) -1
CAH's EPS Growth (%) is ranked lower than
6666660% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. CAH: -1 )
CAH' s 10-Year EPS Growth (%) Range
Min: -22   Max: 18.1
Current: -1
-22
18.1
» CAH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

CAH Guru Trades in Q2 2012

David Dreman 75,621 sh (New)
Scott Black 106,697 sh (+496.74%)
Ray Dalio 112,200 sh (+285.57%)
Manning & Napier Advisors, Inc 23,881 sh (+227.36%)
Joel Greenblatt 37,136 sh (+184.28%)
Steven Cohen 52,494 sh (+28.66%)
Andreas Halvorsen 5,290,226 sh (+2.52%)
James Barrow 3,405,965 sh (+0.29%)
John Keeley 89,900 sh (unchged)
Vanguard Health Care Fund 6,236,708 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons Sold Out
Pioneer Investments 1,565,813 sh (-3.15%)
Larry Robbins 4,640,686 sh (-19.4%)
Jeremy Grantham 62,900 sh (-49.4%)
» More
Q3 2012

CAH Guru Trades in Q3 2012

Jim Simons 1,996,400 sh (New)
John Hussman 1,200 sh (New)
Paul Tudor Jones 614,100 sh (New)
Ray Dalio 230,000 sh (+104.99%)
Scott Black 152,883 sh (+43.29%)
Steven Cohen 63,372 sh (+20.72%)
David Dreman 85,132 sh (+12.58%)
John Keeley 96,490 sh (+7.33%)
Manning & Napier Advisors, Inc 24,346 sh (+1.95%)
Vanguard Health Care Fund 6,236,708 sh (unchged)
Joel Greenblatt Sold Out
James Barrow 3,392,485 sh (-0.4%)
Andreas Halvorsen 5,191,026 sh (-1.88%)
Larry Robbins 4,471,886 sh (-3.64%)
Pioneer Investments 917,692 sh (-41.39%)
Jeremy Grantham 32,648 sh (-48.1%)
» More
Q4 2012

CAH Guru Trades in Q4 2012

Joel Greenblatt 85,742 sh (New)
Steven Cohen 565,875 sh (+792.94%)
John Hussman 2,400 sh (+100%)
James Barrow 4,026,610 sh (+18.69%)
Scott Black 181,008 sh (+18.4%)
Pioneer Investments 994,227 sh (+8.34%)
John Keeley 98,560 sh (+2.15%)
David Dreman 86,090 sh (+1.13%)
Manning & Napier Advisors, Inc 24,511 sh (+0.68%)
Jeremy Grantham 443,692 sh (unchged)
Vanguard Health Care Fund 6,236,708 sh (unchged)
Larry Robbins 3,488,981 sh (-21.98%)
Ray Dalio 115,600 sh (-49.74%)
Andreas Halvorsen 2,145,834 sh (-58.66%)
Jim Simons 726,400 sh (-63.61%)
Paul Tudor Jones 204,100 sh (-66.76%)
» More
Q1 2013

CAH Guru Trades in Q1 2013

John Buckingham 15,923 sh (New)
Steven Cohen 1,014,547 sh (+79.29%)
John Hussman 4,200 sh (+75%)
Jeremy Grantham 764,692 sh (+72.35%)
Vanguard Health Care Fund 8,304,241 sh (+33.15%)
Ray Dalio 147,246 sh (+27.38%)
James Barrow 5,035,210 sh (+25.05%)
John Keeley 107,060 sh (+8.62%)
Manning & Napier Advisors, Inc 26,154 sh (+6.7%)
Larry Robbins Sold Out
Scott Black Sold Out
Jim Simons Sold Out
Pioneer Investments 927,259 sh (-6.74%)
David Dreman 79,212 sh (-7.99%)
Andreas Halvorsen 1,759,100 sh (-18.02%)
Joel Greenblatt 46,563 sh (-45.69%)
Paul Tudor Jones 33,000 sh (-83.83%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Scott Black 2013-03-31 Sold Out 1.1%$41.18 - $47.09 $ 47.176%0
Vanguard Health Care Fund 2013-03-31 Add 33.15%0.35%$41.18 - $47.09 $ 47.176%8304241
Joel Greenblatt 2013-03-31 Reduce -45.69%0.09%$41.18 - $47.09 $ 47.176%46563
James Barrow 2013-03-31 Add 25.05%0.08%$41.18 - $47.09 $ 47.176%5035210
Ray Dalio 2013-03-31 Add 27.38%0.01%$41.18 - $47.09 $ 47.176%147246
John Hussman 2013-03-31 Add 75%$41.18 - $47.09 $ 47.176%4200
Joel Greenblatt 2012-12-31 New Buy0.2%$39.29 - $42.65 $ 47.1716%85742
Scott Black 2012-12-31 Add 18.4%0.17%$39.29 - $42.65 $ 47.1716%181008
Ray Dalio 2012-12-31 Reduce -49.74%0.06%$39.29 - $42.65 $ 47.1716%115600
John Hussman 2012-12-31 Add 100%$39.29 - $42.65 $ 47.1716%2400
Scott Black 2012-09-30 Add 43.29%0.27%$37.75 - $43.5 $ 47.1716%152883
Joel Greenblatt 2012-09-30 Sold Out 0.11%$37.75 - $43.5 $ 47.1716%0
Ray Dalio 2012-09-30 Add 104.99%0.06%$37.75 - $43.5 $ 47.1716%230000
John Hussman 2012-09-30 New Buy$37.75 - $43.5 $ 47.1716%1200
Scott Black 2012-06-30 Add 496.74%0.58%$40.42 - $43.42 $ 47.1713%106697
Joel Greenblatt 2012-06-30 Add 184.28%0.07%$40.42 - $43.42 $ 47.1713%37136
David Dreman 2012-06-30 New Buy0.07%$40.42 - $43.42 $ 47.1713%75621
Ray Dalio 2012-06-30 Add 285.57%0.05%$40.42 - $43.42 $ 47.1713%112200
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about Cardinal Health Inc

First Quarter Sells - Larry Robbins Unloads Large Positions
May 20, 2013
Larry Robbins - First Quarter Sells - Larry Robbins Unloads Large Positions
Guru Larry Robbins of Glenview Capital Management, the vocal activist investor, did some major selling as of March 31, 2013. Robbins unloaded some concentrated bets like long-held Hewlett-Packard Co. (HPQ) for 2.9 million shares, Cardinal Health Inc. (CAH) for 3.4 million shares and Sirius XM Radio Inc. (SIRI) for 10 million shares. Here are Glenview Capital's first quarter 2013 sell out details: [b] Read more...
Screening for Possible Value Traps
July 19, 2012
- Screening For Possible Value Traps
Falling into value traps is one of the biggest mistakes value investors make. Value traps tend to appear cheap, but their business internals are deteriorating – the business is destroying value. We are having a very good discussion about how to avoid value traps here. We pointed out that one of the obvious sign of a value trap is declining profit margins, as seen clearly from companies like Research-In-Motion (RIMM), Nokia (NOK) and RadioShack (RSH). Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 14.20
CAH's P/E(ttm) is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.10 vs. CAH: 14.20 )
CAH' s 10-Year P/E(ttm) Range
Min: 6.29   Max: 29.32
Current: 14.2
6.29
29.32
P/B 2.60
CAH's P/B is ranked lower than
2941174% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.18 vs. CAH: 2.60 )
CAH' s 10-Year P/B Range
Min: 0.88   Max: 4.82
Current: 2.6
0.88
4.82
P/S 0.16
CAH's P/S is ranked lower than
2941174% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.67 vs. CAH: 0.16 )
CAH' s 10-Year P/S Range
Min: 0.08   Max: 0.64
Current: 0.16
0.08
0.64
PFCF 14.70
CAH's PFCF is ranked lower than
3703700% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.50 vs. CAH: 14.70 )
CAH' s 10-Year PFCF Range
Min: 4.33   Max: 235.59
Current: 14.7
4.33
235.59
EV-to-EBIT 9.8
CAH's EV-to-EBIT is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.19 vs. CAH: 9.8 )
CAH' s 10-Year EV-to-EBIT Range
Min: 4.8   Max: 18.6
Current: 9.8
4.8
18.6
PEG 3.7
CAH's PEG is ranked lower than
6666660% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.62 vs. CAH: 3.7 )
CAH' s 10-Year PEG Range
Min: 0.62   Max: 36.19
Current: 3.7
0.62
36.19
Shiller P/E 13.9
CAH's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Distribution industry.

( Industry Median: vs. CAH: 13.9 )
CAH' s 10-Year Shiller P/E Range
Min: 6.02   Max: 24.06
Current: 13.9
6.02
24.06

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 2.17
CAH's Dividend Yield is ranked lower than
3571425% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.47 vs. CAH: 2.17 )
CAH' s 10-Year Dividend Yield Range
Min: 0.15   Max: 2.66
Current: 2.17
0.15
2.66
Dividend Payout 0.3059
CAH's Dividend Payout is ranked lower than
3999996% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. CAH: 0.3059 )
CAH' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.41
Current: 0.31
0.03
0.41
Dividend growth (3y) 12.1
CAH's Dividend growth (3y) is ranked lower than
14285700% of the 7 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.60 vs. CAH: 12.1 )
CAH' s 10-Year Dividend growth (3y) Range
Min: 9   Max: 35.1
Current: 12.1
9
35.1
Yield on cost (5-Year) 4.64
CAH's Yield on cost (5-Year) is ranked lower than
3571425% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.57 vs. CAH: 4.64 )
CAH' s 10-Year Yield on cost (5-Year) Range
Min: 0.32   Max: 5.61
Current: 4.64
0.32
5.61
Share Buyback Rate 0.9
CAH's Share Buyback Rate is ranked lower than
14285700% of the 7 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.90 vs. CAH: 0.9 )
CAH' s 10-Year Share Buyback Rate Range
Min: 4.4   Max: -1.5
Current: 0.9

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 1.9
CAH's Price/Net Current Asset Value is ranked lower than
3030300% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.10 vs. CAH: 1.9 )
CAH' s 10-Year Price/Net Current Asset Value Range
Min: 1   Max: 4.8
Current: 1.9
1
4.8
Price/Tangible Book 8.7
CAH's Price/Tangible Book is ranked lower than
3225803% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.60 vs. CAH: 8.7 )
CAH' s 10-Year Price/Tangible Book Range
Min: 3   Max: 13.6
Current: 8.7
3
13.6
Price/DCF (Projected) 1
CAH's Price/DCF (Projected) is ranked lower than
6249994% of the 16 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.30 vs. CAH: 1 )
CAH' s 10-Year Price/DCF (Projected) Range
Min: 0.3   Max: 1.7
Current: 1
0.3
1.7
Price/Median PS Value 0.7
CAH's Price/Median PS Value is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.20 vs. CAH: 0.7 )
CAH' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 2.1
Current: 0.7
0.3
2.1
Price/Graham Number 2.5
CAH's Price/Graham Number is ranked lower than
3333330% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. CAH: 2.5 )
CAH' s 10-Year Price/Graham Number Range
Min: 1   Max: 3.9
Current: 2.5
1
3.9
Earnings Yield (Greenblatt) 10.20
CAH's Earnings Yield (Greenblatt) is ranked lower than
3124997% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.20 vs. CAH: 10.20 )
CAH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.4   Max: 20.8
Current: 10.2
5.4
20.8
Forward Rate of Return (Yacktman) 4.61
CAH's Forward Rate of Return (Yacktman) is ranked lower than
7142850% of the 14 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.24 vs. CAH: 4.61 )
CAH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 4.5   Max: 22
Current: 4.61
4.5
22

Business Description

Cardinal Health, Inc is an Ohio corporation formed in 1979. The Company is a provider of products and services that improve the safety and productivity of healthcare. It is a global company serving the healthcare industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety and productivity, and deliver better care to patients. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 40,000 locations each day. The Company is also a manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, it supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. On September 29, 2008, the Company announced that it intended to separate its clinical and medical products businesses from its other businesses through a pro rata distribution to its shareholders of common stock of a wholly owned subsidiary, CareFusion Corporation (CareFusion), formed for the purpose of holding the majority of its clinical and medical products businesses. After the Spin-Off, the Company would retain certain surgical and exam gloves, surgical drapes and apparel and fluid management businesses that were previously part of its Clinical and Medical Products segment. Effective upon the Spin-Off, the Company would change its reportable segments to two segments: Pharmaceutical and Medical. Cardinal Health serves retail, hospital, mail-order and long-term care pharmacies by distributing pharmaceuticals and related healthcare products to more than 33,000 locations. The Pharmaceutical segment also provides comprehensive financial, inventory, contract management and marketing services that help its customers reduce costs, improve efficiency and increase profitability. Cardinal Health distributes medical products from more than 2,000 manufacturers to hospitals, surgery centers, laboratories and physician offices throughout the U.S. and Canada. The Medical segment's integrated supply chain and logistics services help customers control costs, improve efficiencies and deliver effective, high-quality care. Cardinal Health offers comprehensive supply chain management solutions that provide access to the right products for the right procedure at exactly the right time - helping to reduce waste, improve clinician productivity and reduce stock-outs. Cardinal Health is also a manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. It completed several acquisitions since July 1, 2010, including the fiscal 2011 acquisitions: Kinray. On December 21, 2010, it completed the acquisition of privately held Kinray, Inc. (Kinray) for $1.3 billion in an all-cash transaction; Cardinal Health Chi
Company Website
SEC Reports
Industry: Medical Distribution
Compare:ABC, MCK, SHTDF, HSIC, PDCO
Traded in other countries:CLH.Germany
» More Articles for CAH

Headlines

Articles On GuruFocus.com
First Quarter Sells - Larry Robbins Unloads Large Positions May 20 2013 
My 3 Favorite Dividend Aristocrats with the Highest Payout Potential Apr 09 2013 
My 4 Favorites from the 20 Most-Recommended Dividend Aristocrats Mar 07 2013 
20 Dividend Contenders with High Growth and Cheap Price Ratios Feb 21 2013 
Magic Formula Formulator Joel Greenblatt’s Top 5 New Stock Picks Feb 14 2013 
My 4 Favorites from the Services Sector with Big Dividends and Strongest Earnings Growth Feb 08 2013 
19 Dividend Aristocrats with the Strongest Expected Earnings Growth Feb 07 2013 
This Week’s Insider Trade Highlights – eBay, Huntington, Cardinal Health, NetSuite Jan 25 2013 
My 3 Favorites from the 20 Contenders Most Recommended Dividend Contenders List Jan 09 2013 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Dec 07 2012 

More From Our Partners
Green Light for WAG and ABC Deal - Analyst Blog May 20 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial